Frequently Asked Questions
The market is segmented based on Global CRISPR Gene-Editing Market, By Therapeutic Application (Oncology and Autoimmune or Inflammatory), Application (Genome Engineering, Disease Models, Functional Genomics, and Others), Technology (CRISPR or Cas9, Zinc Finger Nucleases , and Others), Services (Design Tools, Plasmid and Vector, Cas9 and g-RNA, Delivery System Products, and Others), Products (GenCrispr or Cas9 kits, GenCrispr Cas9 Antibodies, GenCrispr Cas9 Enzymes, and Others), End-Users (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, and Contract Research Organizations, and Others) – Industry Trends and Forecast to 2031.
.
The Global Crispr Gene Editing Market size was valued at USD 1.41 USD Billion in 2023.
The Global Crispr Gene Editing Market is projected to grow at a CAGR of 29.8% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
